EUVIMED · CrossrefZeitschrift
Cancer Gene Therapy
ISSN 0929-1903 · Springer Science and Business Media LLC
Neueste Artikel
Investigating the role of costimulatory domains in enhancing CAR-T cell persistence in TNBC
PAK4 orchestrates dual transcriptional and post-translational repression of E-cadherin to promote epithelial-to-mesenchymal transition and invasiveness in pancreatic cancer
E2F3 amplification primes bladder cancer cells for premature mitosis
Glypican-3-targeted therapy in hepatocellular carcinoma: biological insights and therapeutic strategies
SPARC family proteins: matricellular modulators of cancer progression and therapeutic resistance
Dioscin suppresses tumorigenesis and overcomes radioresistance by promoting ubiquitination-mediated degradation of Mcl-1
Application of CAR-T therapy in solid tumors: current opportunities and challenges
m6A epitranscriptomic regulation of KRAS by METTL3 promotes EMT and stromal remodeling through TGF-β/SMAD signaling in cervical cancer
NRAV promotes HCC stemness via the m6A-regulated let-7c-5p/LIN28B axis
Disulfidptosis in cancer: from redox stress to therapeutic strategy
Meta single-cell atlas and xQTL post-GWAS analysis revealed the pathogenic features of thyroid cancer for target therapy: A multi-omics study
MALNC: a new mutant NPM1/IDH2R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response
Integration of humanized ROBO1 CAR in PD-1 locus in natural killer cells delivers synergistic tumor-killing effect against non-small cell lung cancer
The involvement of lncRNA EMSLR in the disulfidptosis and progression of endometrial carcinoma
Targeting MCM10 disrupts cancer stemness and counteracts sorafenib resistance in hepatocellular carcinoma
Integrated multidimensional bioinformatics analysis of the molecular mechanisms of ulcerative colitis-associated colorectal cancer and MMP1 as a potential therapeutic target
The dual role of GPX4 in breast cancer: mechanisms of therapeutic resistance and potential for novel targeted therapies
Barriers and solutions for CAR-T therapy in solid tumors
APOE deficiency triggers anti-tumour activity of macrophages in liver cancer
Blood-brain barrier alterations as an initiator of brain metastasis from lung cancer: a new take on an old story
AAV for ovarian cancer gene therapy
ARL6IP5 in cancers: bidirectional function and therapeutic value
Hemorrhagic and ischemic risks of anti-VEGF therapies in glioblastoma
Human endogenous retroviruses (HERVs) associated with glioblastoma risk and prognosis
Glioblastoma-associated macrophages in glioblastoma: from their function and mechanism to therapeutic advances
RRM1 O-GlcNAcylation inhibition suppresses pancreatic cancer via TK1-mediated replication stress
Emerging roles of prohibitins in cancer: an update
MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy
ITGA3 promotes pancreatic cancer progression through HIF1α- and c-Myc-driven glycolysis in a collagen I-dependent autocrine manner
The deubiquitinating enzyme ATXN3 promotes hepatocellular carcinoma progression by stabilizing TAZ
EUVIMED